Samsung Pharm Financial Flexibility Index
Samsung Pharm financial flexibility index. Samsung Pharm (001360) has a Financial Flexibility Index of -0.05x as of September 2025. Free cash flow of ₩-2.26 Billion (operating CF ₩-2.29 Billion minus capex ₩30.00 Million) represents 0% of total liabilities (₩44.04 Billion). See 001360 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Samsung Pharm (2012–2024)
Financial flexibility index of Samsung Pharm from 2012 to 2024. Historical Financial Flexibility Index trend for Samsung Pharm across 12 annual periods. Check how high is Samsung Pharm's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Samsung Pharm Financial Flexibility Index by Year (2012–2024)
Samsung Pharm financial flexibility index by year from 2012 to 2024. Year-by-year free cash flow to debt coverage for Samsung Pharm. For the full cash flow conversion analysis, see 001360 cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.75x | ₩-16.91 Billion | ₩-17.30 Billion | ₩22.60 Billion | ▲ +20.0% |
| 2023 | -0.94x | ₩-14.88 Billion | ₩-27.66 Billion | ₩15.89 Billion | ▼ -1380.1% |
| 2022 | 0.07x | ₩1.12 Billion | ₩-1.91 Billion | ₩15.32 Billion | ▲ +142.9% |
| 2021 | -0.17x | ₩-3.10 Billion | ₩-7.16 Billion | ₩18.19 Billion | ▼ -310.3% |
| 2020 | 0.08x | ₩4.60 Billion | ₩-2.55 Billion | ₩56.81 Billion | ▼ -81.8% |
| 2019 | 0.45x | ₩11.45 Billion | ₩-2.43 Billion | ₩25.70 Billion | ▲ +430.4% |
| 2018 | -0.13x | ₩-3.91 Billion | ₩-6.52 Billion | ₩28.98 Billion | ▼ -172.2% |
| 2017 | 0.19x | ₩11.26 Billion | ₩5.15 Billion | ₩60.33 Billion | ▼ -55.2% |
| 2016 | 0.42x | ₩23.29 Billion | ₩-9.94 Billion | ₩55.91 Billion | ▲ +357.0% |
| 2015 | 0.09x | ₩7.66 Billion | ₩-4.20 Billion | ₩83.98 Billion | ▲ +127.1% |
| 2014 | -0.34x | ₩-11.49 Billion | ₩-13.58 Billion | ₩34.12 Billion | ▼ -165.2% |
| 2012 | -0.13x | ₩-8.68 Billion | ₩-11.13 Billion | ₩68.31 Billion | — |